Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Author Replies.
Miyo M, Takemasa I, Ishihara H, Hata T, Mizushima T, Ohno Y, Doki Y, Mori M. Miyo M, et al. Among authors: hata t. Dis Colon Rectum. 2017 Nov;60(11):e631-e632. doi: 10.1097/DCR.0000000000000938. Dis Colon Rectum. 2017. PMID: 28991091 No abstract available.
Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.
Hata T, Yamamoto H, Ngan CY, Koi M, Takagi A, Damdinsuren B, Yasui M, Fujie Y, Matsuzaki T, Hemmi H, Xu X, Kitani K, Seki Y, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M. Hata T, et al. Mol Cancer Ther. 2005 Oct;4(10):1585-94. doi: 10.1158/1535-7163.MCT-05-0011. Mol Cancer Ther. 2005. PMID: 16227409
SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
Suzuki Y, Haraguchi N, Takahashi H, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Ishii H, Doki Y, Mori M, Yamamoto H. Suzuki Y, et al. Among authors: hata t. Int J Oncol. 2013 Jan;42(1):161-7. doi: 10.3892/ijo.2012.1713. Epub 2012 Nov 22. Int J Oncol. 2013. PMID: 23175153
Depletion of JARID1B induces cellular senescence in human colorectal cancer.
Ohta K, Haraguchi N, Kano Y, Kagawa Y, Konno M, Nishikawa S, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Noguchi Y, Ozaki M, Kudo T, Sakai D, Satoh T, Fukami M, Ishii M, Yamamoto H, Doki Y, Mori M, Ishii H. Ohta K, et al. Among authors: hata t. Int J Oncol. 2013 Apr;42(4):1212-8. doi: 10.3892/ijo.2013.1799. Epub 2013 Jan 25. Int J Oncol. 2013. PMID: 23354547
C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M, Yamamoto H, Masuzawa T, Takahashi H, Uemura M, Haraguchi N, Nishimura J, Hata T, Yamasaki M, Miyata H, Takemasa I, Mizushima T, Takiguchi S, Doki Y, Mori M. Ohtsuka M, et al. Among authors: hata t. Ann Surg Oncol. 2013 Aug;20(8):2699-705. doi: 10.1245/s10434-013-2900-2. Epub 2013 Feb 24. Ann Surg Oncol. 2013. PMID: 23435632
A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer.
Hata T, Fukunaga M, Murata K, Uemura Y, Fukuzaki T, Ota H, Ohue M, Ohnishi T, Tanaka N, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Hata T, et al. Cancer Chemother Pharmacol. 2013 Jun;71(6):1657-63. doi: 10.1007/s00280-013-2143-8. Epub 2013 Mar 31. Cancer Chemother Pharmacol. 2013. PMID: 23543294 Clinical Trial.
2,107 results